Short Summary
Apple’s IPR against Omni MedSci’s wearable physiological measurement patent resulted in all challenged claims being held unpatentable. The Board found the claims obvious over Lisogurski, Carlson, and Mannheimer under §103(a).
Detailed Summary
In IPR2019‑00916, Apple challenged claims 5, 7‑10, 13, and 15‑17 of Omni MedSci’s U.S. Patent No. 9,651,533 B2, a wearable physiological measurement system. The Patent Trial and Appeal Board instituted the review on all grounds and, after extensive claim construction and analysis, concluded that the combination of prior‑art references Lisogurski, Carlson, and Mannheimer taught each limitation of the asserted claims. The Board construed “personal device” and “light source” in favor of the petitioner and applied 35 U.S.C. §103(a) to find the claims obvious. Consequently, all nine challenged claims were declared unpatentable.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
LG Electronics, Inc. et al.vsMaxell, LTD.
LG Electronics and Maxell have settled their IPR dispute over U.S. Patent 10,244,284. They jointly moved to have the settlement agreement treated as business confidential information and to terminate the proceeding.
Generac Power Systems, Inc.vsPSLC LLC
Generac Power Systems petitions the PTAB to invalidate PSLC’s ’857 microgrid load‑control patent, asserting that the claims are obvious over a combination of prior‑art references covering frequency‑based load shedding.
Google LLC et al.vsHeadwater Research LLC
This petition challenges patent validity under 35 U.S.C. § 103, asserting that the claimed invention is obvious in light of prior art references Rao and Fadell. The challenge covers a broad scope of claims ranging from Claim 1 to Claim 159.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB denied Imperative Care's petition to institute an IPR against Inari Medical's embolism‑treatment patent, finding no reasonable likelihood of success on any of the 31 challenged claims.
Google LLCvsSecure Communication Technologies, LLC
Google has filed an IPR petition seeking cancellation of 62 claims of Secure Communication Technologies' Bluetooth‑beacon patent, asserting that each claim is anticipated or obvious over Eagle, Behrens, Olkkonen, Kallio and Jones. The petition cites prior PTAB findings and collateral estoppel to bolster its request for institution.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.